Niquitin (Nicotine)

Nicotine, the active ingredient in Niquitin, is a nicotinic receptor agonist presented as an oromucosal formulation for oromucosal use. It is employed to aid adults who wish to quit smoking by reducing withdrawal symptoms and cravings associated with nicotine dependence.

GNH USA supplies Niquitin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable sourcing for regulated markets. Its distribution network ensures timely delivery and compliance with local regulatory requirements.

Niquitin is a nicotinic receptor agonist used in the management of tobacco‑related dependence. It helps individuals transition away from nicotine by alleviating withdrawal.

- Smoking cessation: reduces cravings and withdrawal symptoms during quit attempts. - Tobacco dependence: supports gradual reduction of nicotine intake. - Nicotine addiction: assists in managing dependence for adult smokers seeking to quit.

Niquitin may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation or soreness - Nausea or upset stomach - Hiccups or throat tickle - Dizziness or light‑headedness - Headache - Increased salivation

Serious or Rare Side Effects: - Throat swelling or difficulty breathing - Allergic reactions such as rash or urticaria - Chest pain or palpitations - Arrhythmias - Severe nausea or vomiting - Marked hypotension

Before using Niquitin, consider the following safety measures.

- Assess nicotine dependence level: determine appropriate therapy intensity. - Avoid use in children and adolescents: not indicated for persons under legal smoking age. - Do not combine with other nicotine replacement products: risk of nicotine overdose. - Monitor cardiovascular status: caution in patients with heart disease. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Niquitin can interact with other medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis. - Concurrent nicotine replacement therapies: risk of nicotine toxicity.

Moderate Interactions (Monitor Closely): - Caffeine: may enhance jitteriness or palpitations. - Alcohol: can increase central nervous system effects. - Selective serotonin reuptake inhibitors (SSRIs): possible alteration of nicotine metabolism.